Literature DB >> 9187010

No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.

M Verga1, F Macciardi, S Pedrini, S Cohen, E Smeraldi.   

Abstract

Arinami et al. (1994) reported an association between the Ser311/Cys311 variant of the DRD2 gene and schizophrenia in a Japanese population. We did not find statistically significant differences in the distribution of the allele frequencies between schizophrenics (103) and controls (97) in a case-control sample (chi 2 = 2.07; p = 0.150) or in 64 nuclear families with the haplotype relative risk (HRR) design (chi 2 = 0.13; p = 0.718). Our results seem to exclude a main involvement of this variant of the dopamine D2 receptor gene in the etiopathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187010     DOI: 10.1016/S0920-9964(97)00013-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Authors:  Stephen J Glatt; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

Review 2.  Genetic polymorphisms in the expression and treatment of neuropsychiatric disorders.

Authors:  Thomas W McAllister; Lanier Summerall
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

3.  Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan.

Authors:  S J Glatt; S V Faraone; J A Lasky-Su; T Kanazawa; H-G Hwu; M T Tsuang
Journal:  Mol Psychiatry       Date:  2008-03-11       Impact factor: 15.992

4.  A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples.

Authors:  O S Cohen; T W Weickert; J L Hess; L M Paish; S Y McCoy; D A Rothmond; C Galletly; D Liu; D D Weinberg; X-F Huang; Q Xu; Y Shen; D Zhang; W Yue; J Yan; L Wang; T Lu; L He; Y Shi; M Xu; R Che; W Tang; C-H Chen; W-H Chang; H-G Hwu; C-M Liu; Y-L Liu; C-C Wen; C S-J Fann; C-C Chang; T Kanazawa; F A Middleton; T M Duncan; S V Faraone; C S Weickert; M T Tsuang; S J Glatt
Journal:  Mol Psychiatry       Date:  2015-09-08       Impact factor: 15.992

5.  Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis.

Authors:  Hairong He; Huanhuan Wu; Lihong Yang; Fan Gao; Yajuan Fan; Junqin Feng; Xiancang Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-09       Impact factor: 2.570

6.  Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia.

Authors:  Bao-Yu Chen; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Sheng-Hsiang Lin
Journal:  NPJ Schizophr       Date:  2021-07-05

7.  Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.

Authors:  Neetha N Vijayan; Sujatha Bhaskaran; Linda V Koshy; Chandrasekhar Natarajan; Lekshmy Srinivas; Chandrasekharan M Nair; Priya M Allencherry; Moinak Banerjee
Journal:  Behav Brain Funct       Date:  2007-07-25       Impact factor: 3.759

Review 8.  The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Alma Genis-Mendoza; Mariela Alpuin-Reyes
Journal:  Behav Brain Funct       Date:  2016-11-09       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.